Sebree Terri B - Insider Non-Derivative Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Oct 10, 2023, Sebree Terri B's relationship to Zynerba Pharmaceuticals, Inc. (ZYNE) is Officer (President), and currently has 425,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ZYNE insiders.

Data Source: SEC.
Sebree Terri B - Insider Non-Derivative Transactions of ZYNE Common Stock
Sebree Terri B - Insider Non-Derivative Transactions at ZYNE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 11, 2023 U -- (Common Stock) 425000 0 0
Oct 11, 2023 U -- (Common Stock) 341241 0 255000
Oct 11, 2023 Acquisition -- (Common Stock) 170000 0 425000
Sep 14, 2023 Sell -- (Common Stock) 12401 1.33 596241
Sep 13, 2023 Acquisition -- (Common Stock) 45000 0 608642
Feb 9, 2023 F -- (Common Stock) 9973 0.6 563642
Feb 8, 2023 Acquisition -- (Common Stock) 36044 0 573615
Feb 2, 2023 F -- (Common Stock) 9321 0.6 537571
Feb 1, 2023 Acquisition -- (Common Stock) 33688 0 546892
Jan 25, 2023 Acquisition -- (Common Stock) 170000 0 513204
Jan 24, 2023 Sell -- (Common Stock) 24661 0.6 343204